Summit Therapeutics falls after update on Akeso-partnered...

2026-05-01 09:59:22 ET More on Summit Therapeutics Summit Therapeutics: It Still Feels Like The Market Got Ahead Of Itself Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript Summit Therapeutics Inc. (SMMT) Presents at TD Cowen 46th Annual Health Care Conference Transcript Summit Therapeutics GAAP EPS of -$0.24 beats by $0.04 Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season Read the full article on Seeking Alpha For further details see: Summit Therapeutics falls after update on Akeso-partnered lung cancer trial